Education
About Us
Working with TipRanks
Follow Us
DIVD - AI Analysis
Top Page
Altrius Global Dividend ETF Altrius Global Divid ETF (DIVD)
Rating:69Neutral
Price Target:
$41.00
Positive Factors
Strong Top Holdings
Several of the ETF's largest positions, such as Siemens AG and Banco Bilbao, have delivered strong year-to-date performance, supporting overall returns.
Sector Diversification
The ETF is spread across 10 different sectors, reducing the risk of being overly reliant on one industry.
Reasonable Expense Ratio
The fund has a relatively low expense ratio compared to many actively managed ETFs, helping investors keep more of their returns.
Negative Factors
High Geographic Concentration
With over 97% of its exposure in U.S. companies, the ETF lacks diversification across global markets.
Underperforming Holdings
Some top holdings, such as Sanofi and Royal Bank of Canada, have shown weaker year-to-date performance, which may drag on overall returns.
Small Asset Base
The ETF has relatively low assets under management, which could lead to higher trading costs and less liquidity for investors.
DIVD vs. SPDR S&P 500 ETF (SPY)
AUM12.59M
RegionGlobal
Expense Ratio0.49%
Beta0.62
IssuerAltrius
Inception DateSep 29, 2022
Dividend Yield2.93%
Asset ClassEquity
Index TrackedNo Underlying Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume2,065
30 Day Avg. Volume3,407
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
40.16Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering65
DIVD Summary
The Altrius Global Dividend ETF (DIVD) is an investment fund focused on companies worldwide that pay strong dividends, making it ideal for investors seeking consistent income and international diversification. It includes well-known companies like Nestlé and GlaxoSmithKline, spanning sectors such as healthcare, consumer goods, and finance. This ETF is a great option for those looking to combine income with growth potential from global markets. However, new investors should be aware that its performance is heavily tied to dividend-paying stocks, which can fluctuate with market conditions.
How much will it cost me?The Altrius Global Dividend ETF (DIVD) has an expense ratio of 0.49%, which means you’ll pay $4.90 per year for every $1,000 invested. This expense ratio is slightly higher than average for ETFs because it is actively managed, focusing on selecting global dividend-paying stocks rather than tracking a passive index.
What would affect this ETF?The Altrius Global Dividend ETF (DIVD) could benefit from global economic growth and increased demand for dividend-paying stocks, especially in sectors like Health Care and Consumer Defensive, which are known for stability and resilience. However, potential risks include rising interest rates, which may make dividend-focused investments less attractive, and geopolitical or regulatory challenges that could impact global markets and specific regions where the ETF is invested. Additionally, sector-specific issues, such as volatility in the Energy or Financial sectors, could negatively affect performance.
DIVD Top 10 Holdings
The Altrius Global Dividend ETF (DIVD) leans heavily into healthcare and consumer defensive sectors, with names like Novartis and Nestlé providing steady growth and reliable dividends that align with the fund’s income-focused strategy. Siemens AG is rising on strong financial performance, adding a spark from the industrials sector, while Banco Bilbao stands out as a top performer, driving gains from the financial space. However, Royal Bank of Canada is lagging slightly, tempering the fund’s overall momentum. With its global mix, DIVD offers a diversified approach to dividend investing, balancing stability with selective growth opportunities.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| GlaxoSmithKline | 2.38% | $301.30K | $87.65B | 14.49% | 72 Outperform | |
| Nestle SA Reg | 2.38% | $301.18K | $252.75B | 4.20% | 74 Outperform | |
| AstraZeneca | 2.36% | $298.92K | $255.14B | 9.82% | 77 Outperform | |
| Siemens AG | 2.30% | $291.38K | $224.61B | 47.12% | 78 Outperform | |
| Toyota Motor | 2.29% | $290.19K | $272.07B | 20.00% | 70 Outperform | |
| Sanofi | 2.28% | $289.49K | $123.89B | -5.14% | 76 Outperform | |
| Novartis | 2.28% | $288.63K | $237.12B | 11.67% | 78 Outperform | |
| Banco Bilbao | 2.26% | $286.46K | $115.09B | 106.05% | 64 Neutral | |
| Roche Holding | 2.23% | $282.30K | $263.69B | 2.51% | 69 Neutral | |
| Royal Bank Of Canada | 2.21% | $280.60K | $209.51B | 20.72% | 75 Outperform |
DIVD Technical Analysis
Positive
―
Price Trends
36.78
Positive
36.19
Positive
34.74
Positive
Market Momentum
0.11
Negative
54.71
Neutral
86.54
Negative
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For DIVD, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 36.90, equal to the 50-day MA of 36.78, and equal to the 200-day MA of 34.74, indicating a bullish trend. The MACD of 0.11 indicates Negative momentum. The RSI at 54.71 is Neutral, neither overbought nor oversold. The STOCH value of 86.54 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for DIVD.
DIVD Peer Comparison
Comparison Results
Performance Comparison
DIVD
Altrius Global Dividend ETF Altrius Global Divid ETF
37.04
4.76
14.75%
FDIV
MarketDesk Focused U.S. Dividend ETF
―
―
―
DIVY
Sound Equity Income ETF
―
―
―
VWID
Virtus WMC International Dividend ETF
―
―
―
JHID
John Hancock International High Dividend ETF
―
―
―
GENW
Genter Capital International Dividend ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents